banner

blank blank
blank
blank

blank

ONLINE LEARNING CENTER
print
 

Prevention and Treatment of HIV Infection in Persons 50 and Over (09HC05)

 
 

ACTIVITY INFORMATION

Release Date: May 1, 2007
Expiration Date: October 31, 2008
Activity Code: 09HC05-DE01

Sponsor

Sponsored by the University of Medicine & Dentistry of New Jersey (UMDNJ), UMDNJ-Center for Continuing & Outreach Education..

Grantor Acknowledgement

This activity is supported by an educational grant from NJDHSS Division of HIV/AIDS Services through a MOA titled “Education and Training for Physicians and other Healthcare Professionals in the Diagnosis and Treatment of HIV/AIDS.” Additional support is provided by the New York/ New Jersey AIDS Education and Training Center

Target Audience

This activity is designed for physicians and nurses, and for other health care professionals in New Jersey who are involved in the care of persons with HIV/AIDS.

Statement of Need

In New Jersey and nationwide, public health officials have documented a dramatic increase in the number and proportion of adults 50 and over infected with the Human Immunodeficiency Virus (HIV), including those who have progressed to Acquired Immune Deficiency Syndrome (AIDS).1,2

By June 2006, the New Jersey Department of Health and Senior Services, Division of HIV/AIDS Services (NJDHSS-DHAS) reported that the percentage of the HIV/AIDS-infected population who were 50 or older had risen to 30% of all cases of HIV/AIDS in New Jersey, a total of 10,082 people age 50 or older.2

This article is designed to enhance the role of New Jersey’s clinicians in reducing the transmission of HIV among people 50 and older, identifying those who are HIV-positive but not yet in treatment, and enhancing care of the growing population of patients coping simultaneously with HIV infection and aging.

1. Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention. Number of adolescents and adults living with AIDS, by age as of December 31, 2000 and race/ethnicity – United States, 2000.
2. NJDHSS. New Jersey HIV/AIDS Report – June 30, 2006. http://www.state.nj.us/health/aids/qtr0606.pdf

Learning Objectives

Upon completion of this learning activity, the reader should be able to:

  • Describe the characteristics of people age 50 and older, in New Jersey and nationally, with HIV/AIDS.

  • Identify factors in the aging process which complicate the effects and treatment of HIV infection.

  • Discuss age-specific recommendations for effective HIV screening and testing

  • Outline common co-morbidities and appropriate diagnostic approaches for the HIV-positive patient 50 and older.

Method of Instruction

Participants should read the learning objectives and review the activity in its entirety. After reviewing the material, complete the self-assessment test consisting of a series of multiple-choice and True/ False questions. Upon completing this activity as designed and achieving a passing score of 70% or more on the self-assessment test, participants will receive a credit letter. Estimated time to complete this activity as designed is 1.0 hour.

Accreditation

Physicians:
UMDNJ–Center for Continuing and Outreach Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. UMDNJ–Center for Continuing and Outreach Education designates this educational activity for a maximum of 1.0 hour of AMA PRA category 1 credit™. Each physician should claim only those credits that he/she actually spent in the activity.

Nurses:
The University of Medicine and Dentistry of New Jersey-Continuing Education and Outreach Education is an approved provider of continuing nursing education by the New Jersey State Nurses Association, Provider Number P173-10/06-09. New Jersey State Nurses Association is accredited by the American Nurses Credentialing Center's Commission on Accreditation. This activity is awarded 1.0 contact hour.

UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing education by the California Board of Registered Nursing, Provider Number CEP 13780 for a maximum of 1.0 contact hour for this activity.

Review

The activity was prepared in accordance with the ACCME Essentials. This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Patricia Kloser, MD, MPH. This activity was reviewed for relevance, accuracy of content, balance of presentation, and time required for participation by Bonnie Abedini, MSN, RN; Mary C. Krug, MSN, RN, APN-C; and Debbie Y. Mohammed, MS, APRN-BC, ACRN.

Faculty

Robert Skeist, MS, RN, ACRN is a Geriatric Nurse, Family Treatment Center, Newark Beth Israel Medical Center in Newark, NJ.

Eliahu Bishburg, MD is Director of Infectious Diseases at the Newark Beth Israel Medical Center and Director of the Family Treatment Center in Newark, NJ.

Sindy M. Paul, MD, MPH, FACPM, is Medical Director for the New Jersey Department of Health and Senior Services (NJDHSS), Division of HIV/AIDS Services; Assistant Clinical Professor at the University of Medicine and Dentistry of New Jersey (UMDNJ); and President, New Jersey Board of Medical Examiners

Rose Marie Martin, MPH, is Research Scientist (retired), NJDHSS – DHAS and Adjunct Instructor, Biostatistics, UMDNJ School of Public Health.

Disclosure

Patricia Kloser, MD, MPH (Field Tester and Activity Director) has the following financial relationships to disclose: Speaker’s Bureau: GlaxoSmithKline, Abbott; Consultant: Gilead,Boehringer Ingleheim. The following have no financial relationships to disclose: Robert Skeist, ACRN, MS; Eliahu Bishburg, MD; Sindy Paul, MD, MPH; Rose Marie Martin, MPH and field testers: Bonnie Abedini, MSN, RN; Mary C.Krug, RN, MSN, APN-C; and Debbie Y.Mohammed, MS, APRN-BC, ACRN.

Faculty Disclosure Declarations

Patricia Kloser, MD, MPH (Field Tester and Activity Director) has the following financial relationships to disclose: Speaker’s Bureau: GlaxoSmithKline, Abbott; Consultant: Gilead,Boehringer Ingleheim. The following have no financial relationships to disclose: Robert Skeist, ACRN, MS; Eliahu Bishburg, MD; Sindy Paul, MD, MPH; Rose Marie Martin, MPH and field testers: Bonnie Abedini, MSN, RN; Mary C.Krug, RN, MSN, APN-C; and Debbie Y.Mohammed, MS, APRN-BC, ACRN.

Off-Label Usage Disclosure

This activity does not contain information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved.

Disclaimer

The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of NJDHSS-Division of HIV/AIDS Services, UMDNJ, or any manufacturer of pharmaceuticals. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult the full prescribing information on any agent(s) presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. This is particularly important when a drug is new or infrequently prescribed.

Copyright © 2007 UMDNJ-Center for Continuing & Outreach Education. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval systems, without permission in writing from UMDNJ-Center for Continuing & Outreach Education.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
© UMDNJ-Center for Continuing & Outreach Education | Privacy Policy | System Requirements